The mGluR theory of fragile X mental retardation
- PMID: 15219735
- DOI: 10.1016/j.tins.2004.04.009
The mGluR theory of fragile X mental retardation
Abstract
Many of the diverse functional consequences of activating group 1 metabotropic glutamate receptors require translation of pre-existing mRNA near synapses. One of these consequences is long-term depression (LTD) of transmission at hippocampal synapses. Loss of fragile X mental retardation protein (FMRP), the defect responsible for fragile X syndrome in humans, increases LTD in mouse hippocampus. This finding is consistent with the growing evidence that FMRP normally functions as a repressor of translation of specific mRNAs. Here we present a theory that can account for diverse neurological and psychiatric aspects of fragile X syndrome, based on the assumption that many of the protein-synthesis-dependent functions of metabotropic receptors are exaggerated in fragile X syndrome. The theory suggests new directions for basic research as well as novel therapeutic approaches for the treatment of humans with fragile X, the most frequent inherited cause of mental retardation and an identified cause of autism.
Similar articles
-
Altered synaptic plasticity in a mouse model of fragile X mental retardation.Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50. doi: 10.1073/pnas.122205699. Proc Natl Acad Sci U S A. 2002. PMID: 12032354 Free PMC article.
-
Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.J Neurophysiol. 2006 May;95(5):3291-5. doi: 10.1152/jn.01316.2005. Epub 2006 Feb 1. J Neurophysiol. 2006. PMID: 16452252
-
Therapeutic implications of the mGluR theory of fragile X mental retardation.Genes Brain Behav. 2005 Aug;4(6):393-8. doi: 10.1111/j.1601-183X.2005.00135.x. Genes Brain Behav. 2005. PMID: 16098137 Review.
-
Fragile X mental retardation protein in plasticity and disease.J Neurosci Res. 2002 Dec 1;70(5):623-30. doi: 10.1002/jnr.10453. J Neurosci Res. 2002. PMID: 12424729 Review.
-
Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.J Neurosci. 2012 Apr 25;32(17):5924-36. doi: 10.1523/JNEUROSCI.4650-11.2012. J Neurosci. 2012. PMID: 22539853 Free PMC article.
Cited by
-
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.Int J Physiol Pathophysiol Pharmacol. 2012;4(3):140-8. Epub 2012 Sep 20. Int J Physiol Pathophysiol Pharmacol. 2012. PMID: 23071871 Free PMC article.
-
Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography-What Can be Interpreted from the Available Information?Brain Sci. 2015 Mar 27;5(2):92-117. doi: 10.3390/brainsci5020092. Brain Sci. 2015. PMID: 25826237 Free PMC article. Review.
-
Mutations causing syndromic autism define an axis of synaptic pathophysiology.Nature. 2011 Nov 23;480(7375):63-8. doi: 10.1038/nature10658. Nature. 2011. PMID: 22113615 Free PMC article.
-
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4).Bioorg Med Chem Lett. 2016 Jul 1;26(13):2984-2987. doi: 10.1016/j.bmcl.2016.05.029. Epub 2016 May 11. Bioorg Med Chem Lett. 2016. PMID: 27234146 Free PMC article.
-
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.Psychopharmacology (Berl). 2013 Jul;228(1):75-84. doi: 10.1007/s00213-013-3022-z. Epub 2013 Feb 24. Psychopharmacology (Berl). 2013. PMID: 23436129 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical